Nicolas Delanoy - Hopital Europeen Georges-Pompidou (Hopitaux Universitaires Paris-Ouest)

基本信息

Career Trajectory

Bio

Nicolas Delanoy currently works at the Department of Medical onocology at european George Pompdou hospital. Nicolas does research in Oncology. His most recent publication is Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study.

Research Interests

Papers共 65 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

722P Long-term Patient-Reported Outcomes (pros) with Atezolizumab (atezo) + Bevacizumab (bev) and Chemotherapy (CT) for Metastatic, Persistent or Recurrent Cervical Cancer (R/M CC): BEATcc (Engot-Cx10/geico 68-C/JGOG1084/GOG-3030) Randomised Phase III Trial

L. Gladieff,J. Martinez-Garcia, M. Takekuma,G. Villacampa, U. De Giorgi, P. Harter,K. Hellman,L. Duska, A. Godoy Ortiz,C. Bellier, H. Nishio,M.J. Rubio Pérez,N. Delanoy,L. Fariñas Madrid,D. Berton,J.D. Alarcon,J.E. Kurtz, K. Nishino,L.M. Randall, A. Oaknin

Annals of Oncology (2024)

Cited0Views0Bibtex

Dynamic Changes Intp53mutated Circulating Tumor DNA Predicts Outcome of Patients with High-Grade Ovarian Carcinomas

Maria Kfoury, Clement Bonnet,Nicolas Delanoy,Karen Howarth,Christophe Marzac,Etienne Rouleau,Jean-Baptiste Micol,Alexandra Leary

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2024)

Cited0Views0WOSBibtex

Immune Features of Ovarian Tumors with a Good Response to Neo-Adjuvant Chemotherapy in Combination with an Anti-Pd-l1 Alone or with an Anti-Ctla4: Data from the Randomized IneOV Trial (a GINECO Study)

Alexandra Leary,Laure Chardin,Catherine Genestie,Alain Lortholary,Jerome Alexandre,Thibault De La Motte Rouge,Veronique D'hondt,Anne Floquet,Aude-Marie Savoye,Nicolas Delanoy,Celine Gavoille,Benoit You,Julien Grenier,Elisa Yaniz-Galende

Journal of clinical oncologyno. 16_suppl (2023): 5586-5586

Cited0Views0Bibtex

815P Clinical Outcome of Metastatic Endometrial Carcinoma Patients Treated with Chemotherapy: ENDOVIE, a GINECO National Observational Cohort Study

J. Alexandre,P. Boudier,E. Kalbacher,B. Asselain, E. Lavit, S. Emambux,D. Berton-Rigaud, G. Babin, C. Lescure,P-E. Heudel, H. Salaun,N. Delanoy, H. Dawood, P-F. Combe, D. Duliege,F. Selle,A. Hakme,L. Cagnan,J. Niogret,S. De Percin

Annals of oncology (2023): S539-S540

Cited0Views0Bibtex

Real-world dostarlimab use in advanced/recurrent endometrial cancer in France

Manuel Rodrigues,Lauriane Eberst,Philippe Follana, Ludiane Gauthier, Virginie Jacquemin, Christophe Tessier,Nadia El Mouaddin,Philippe Boudier,Frederic Fiteni,Eurydice Angeli, Sophie Roche,Nicolas Delanoy,Renaud Sabatier,Ronan Flippot,Thibault de la Motte Rouge

Bulletin du cancer（2023）

Cited0Views0WOSBibtex

Real-world Dostarlimab Use in Advanced/recurrent Endometrial Cancer in France

Bulletin du Cancerno. 10 (2023): 1041-1050

Cited0Views0Bibtex

Patterns of Recurrence in Surgically Treated Women for TP53-mutated Endometrial Carcinomas

Flore-Anne Pain,Guillaume Beinse,Henri Azaïs,Marie Auvray-Kuentz, Louis-Marie Garcin,Nicolas Delanoy,Enrica Bentivegna,Louise Benoit,Huyen-Thu Nguyen-Xuan,Hélène Blons,Emmanuelle Fabiano,Marie-Aude LE Frère Belda,Anne-Sophie Bats,Meriem Koual

European journal of surgical oncologyno. 9 (2023): 106954-106954

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn